Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy
Expert Opinion on Drug Safety(2022)
Abstract
SARS CoV-2 infection in pregnant women has become an urgent medical concern since it has been demonstrated a high rate of severe course of COVID-19, with evidence of increased mortality and peri-partum complications, especially when the infect.
MoreTranslated text
Key words
COVID-19, maternal infection, monoclonal antibodies, pregnancy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined